Costs and utilization associated with pharmaceutical adherence in a diabetic population.
about
A Narrative Review of Diabetes Intervention Studies to Explore Diabetes Care Opportunities for PharmacistsAdherence to oral diabetes medications and glycemic control during and following breast cancer treatment.Getting less of what you want: reductions in statistical power and increased bias when categorizing medication adherence data.Development and evaluation of an improved methodology for assessing adherence to evidence-based drug therapy guidelines using claims data.Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia?Adherence feedback to improve asthma outcomes among inner-city children: a randomized trial.Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trialDoes medication adherence lower Medicare spending among beneficiaries with diabetes?How patient cost-sharing trends affect adherence and outcomes: a literature review.Characteristics Relating to Adherence and Persistence to Basal Insulin Regimens Among Elderly Insulin-Naïve Patients with Type 2 Diabetes: Pre-Filled Pens versus Vials/Syringes.Adherence to Oral Antihyperglycemic Agents Among Older Adults With Mental Disorders and Its Effect on Health Care Costs, Quebec, Canada, 2005-2008.The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review.Assessment of self-reported adherence among patients with type 2 diabetes in Matlala District Hospital, Limpopo Province.Adherence to glyburide and metformin and associated factors in type 2 diabetes in isfahan, iran.Simulated value-based insurance design applied to statin use by Medicare beneficiaries with diabetes.Adherence and health care costs.Medication adherence and glycemic control among newly diagnosed diabetes patientsRegular Insulin Administered With the V-Go Disposable Insulin Delivery Device in a Clinical Diabetes Setting: A Retrospective Analysis of Efficacy and Cost
P2860
Q26744229-446AF411-59FB-484C-8614-10863A3055BBQ27331637-CF46C7E0-C24E-4522-A1D7-EA35CC704658Q31049583-245B110B-50C2-4FF1-B9A2-59E0725CF080Q31170820-D2DFA4A6-9BB9-439B-962C-3BF4470FACD0Q33707663-BD4AAB54-8235-4680-A04C-F661ECD76DFFQ33743981-4CF3B1ED-F0F1-4782-8C0D-525A7E0C2134Q34713962-6A9696CD-20F0-4F88-B05A-DCA30952C0C0Q35089645-E3E651B2-58A0-4BB9-AA54-F462A42A5A11Q35752951-9F7A2075-E0E5-4E2D-850F-D5CD1B925360Q36373702-92BFC512-A601-458A-BC5B-F034F037675FQ36426092-6D793206-7814-44FB-83CB-D2272AB6DDBCQ36573967-E1BCCC5E-6E4B-480C-97E4-C53AE854843AQ37191966-2A4589F3-0749-4816-9756-941AE3075470Q37268117-D7ABCB66-C4E1-47EC-9C40-143B18736583Q37394557-E942C391-B817-473A-81F9-D9B73D281666Q37603117-76B0B519-A3C7-45D6-89BE-D578F7CCC250Q41544336-7BBFCD4D-F9AA-405D-9C07-F2A311B30C53Q41637440-87DCCC56-6DCF-4579-B248-B5864995CDE8
P2860
Costs and utilization associated with pharmaceutical adherence in a diabetic population.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Costs and utilization associated with pharmaceutical adherence in a diabetic population.
@ast
Costs and utilization associated with pharmaceutical adherence in a diabetic population.
@en
type
label
Costs and utilization associated with pharmaceutical adherence in a diabetic population.
@ast
Costs and utilization associated with pharmaceutical adherence in a diabetic population.
@en
prefLabel
Costs and utilization associated with pharmaceutical adherence in a diabetic population.
@ast
Costs and utilization associated with pharmaceutical adherence in a diabetic population.
@en
P2093
P1476
Costs and utilization associated with pharmaceutical adherence in a diabetic population
@en
P2093
David A Share
Kera L Hepke
Mary T Martus
P304
P433
P577
2004-02-01T00:00:00Z